CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

This study looks at the long-term safety and effectiveness of a drug called lunsekimig in adults with chronic sinusitis and nasal polyps that are not well controlled. Participants must have completed a previous lunsekimig study. The trial lasts about 56 weeks and measures side ef…

This study looks at the long-term safety of a drug called itepekimab for adults with chronic sinusitis and nasal polyps that are not well controlled. Participants who completed a previous itepekimab study will continue receiving the drug for another year. The goal is to see if it…

This study tests a new drug called GR1802 in 228 adults with severe chronic sinusitis and nasal polyps. The goal is to see if it can shrink polyps, ease congestion, and reduce the need for surgery or steroid pills. Participants receive injections every two weeks for 13 months and…

This study tests a drug called itepekimab for adults with chronic sinusitis and nasal polyps that are not well controlled. About 231 participants will receive either the drug or a placebo for 52 weeks, along with standard nasal spray. The goal is to see if itepekimab can shrink p…

This study follows 100 adults with severe chronic sinusitis and nasal polyps who are starting biologic treatments. Researchers will track changes in symptoms and quality of life over six months using standard questionnaires. The goal is to see how well these drugs work in real-wo…

This observational study follows 40 adults with chronic sinusitis with nasal polyps, with or without severe asthma, who are starting mepolizumab. Researchers collect nasal, blood, and sputum samples before treatment and at 3, 6, and 12 months to track changes in symptoms, gene ac…